Our Patent Litigation team is a proud partner to the world’s most innovative life sciences and technology companies. Our experience successfully handling high-stakes patent matters, joined with Paul, Weiss's legendary litigation capabilities, enable us to provide comprehensive strategies to protect our clients’ most valuable innovations that extend well beyond traditional patent litigation.
Patent Law: 'MedImmune' Ruling
February 19, 2007 Full PDF
Litigation partner Lew Clayton's "Patent Law" column appeared in the February 19 issue of The National Law Journal. The article reports on the U.S. Supreme Court's ruling in MedImmune, Inc. v. Genentech, Inc., which has stimulated debate on the rights of patent owners to discourage licensee challenges to patent validity or enforceability. The article raises questions on whether certain restrictions on challenges in license agreements should be enforced and provides thoughts on the future impact of the MedImmune ruling. Associate Larry Coury assisted in the preparation of the article.